MX360905B - Polimixinas, composiciones, metodos de preparacion y metodos de uso. - Google Patents

Polimixinas, composiciones, metodos de preparacion y metodos de uso.

Info

Publication number
MX360905B
MX360905B MX2015008878A MX2015008878A MX360905B MX 360905 B MX360905 B MX 360905B MX 2015008878 A MX2015008878 A MX 2015008878A MX 2015008878 A MX2015008878 A MX 2015008878A MX 360905 B MX360905 B MX 360905B
Authority
MX
Mexico
Prior art keywords
methods
polymyxins
compositions
making
xch2n
Prior art date
Application number
MX2015008878A
Other languages
English (en)
Spanish (es)
Other versions
MX2015008878A (es
Inventor
Gunnes Sølvi
Bjørnstad Vidar
Koch Torben
Melander Claes
Mänsson Martin
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of MX2015008878A publication Critical patent/MX2015008878A/es
Publication of MX360905B publication Critical patent/MX360905B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
MX2015008878A 2013-01-11 2014-01-09 Polimixinas, composiciones, metodos de preparacion y metodos de uso. MX360905B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US201361904793P 2013-11-15 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (2)

Publication Number Publication Date
MX2015008878A MX2015008878A (es) 2015-10-30
MX360905B true MX360905B (es) 2018-11-21

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008878A MX360905B (es) 2013-01-11 2014-01-09 Polimixinas, composiciones, metodos de preparacion y metodos de uso.

Country Status (20)

Country Link
US (1) US10640536B2 (OSRAM)
EP (1) EP2943503B1 (OSRAM)
JP (1) JP6316846B2 (OSRAM)
KR (1) KR20150107793A (OSRAM)
CN (1) CN104918951B (OSRAM)
AU (1) AU2014204873B2 (OSRAM)
BR (1) BR112015016548A2 (OSRAM)
CA (1) CA2895910C (OSRAM)
EA (1) EA027067B1 (OSRAM)
ES (1) ES2641017T3 (OSRAM)
HU (1) HUE034562T2 (OSRAM)
IL (1) IL239840A (OSRAM)
MX (1) MX360905B (OSRAM)
PT (1) PT2943503T (OSRAM)
RU (1) RU2015132569A (OSRAM)
SI (1) SI2943503T1 (OSRAM)
TW (1) TWI613219B (OSRAM)
UA (1) UA117673C2 (OSRAM)
WO (1) WO2014108469A1 (OSRAM)
ZA (1) ZA201504565B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA117673C2 (uk) 2013-01-11 2018-09-10 Кселлія Фармасьютікалз Апс Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
EA201692569A1 (ru) 2014-07-09 2017-05-31 Кселлия Фармасьютикалз Апс Полимиксины с низкой степенью замещения и композиции, их содержащие
ES2721401T3 (es) 2014-10-03 2019-07-31 Xellia Pharmaceuticals Aps Dispositivo de inhalación
WO2016050928A1 (en) * 2014-10-03 2016-04-07 Xellia Pharmaceuticals Aps Compositions
CA2970546A1 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
EP3356387B1 (en) * 2015-09-29 2024-06-26 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
US20230141981A1 (en) 2020-01-21 2023-05-11 Shanghai Micurx Pharmaceuticals Co., Ltd Novel compounds and composition for targeted therapy of kidney-associated cancers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (OSRAM) * 1968-02-12 1970-03-06
JPH02504003A (ja) * 1988-04-07 1990-11-22 シャンブロム,エドワード 非トロンボゲン形成性脈管内タイムリリースカテーテル
ATE202481T1 (de) 1996-11-15 2001-07-15 Pathogenesis Corp Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
UA117673C2 (uk) 2013-01-11 2018-09-10 Кселлія Фармасьютікалз Апс Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
EA201692569A1 (ru) 2014-07-09 2017-05-31 Кселлия Фармасьютикалз Апс Полимиксины с низкой степенью замещения и композиции, их содержащие
WO2016050928A1 (en) 2014-10-03 2016-04-07 Xellia Pharmaceuticals Aps Compositions

Also Published As

Publication number Publication date
IL239840A (en) 2017-09-28
CN104918951A (zh) 2015-09-16
WO2014108469A1 (en) 2014-07-17
ES2641017T3 (es) 2017-11-07
KR20150107793A (ko) 2015-09-23
US10640536B2 (en) 2020-05-05
US20160002296A1 (en) 2016-01-07
RU2015132569A (ru) 2017-02-14
ZA201504565B (en) 2016-11-30
BR112015016548A2 (pt) 2017-07-11
AU2014204873B2 (en) 2017-07-06
UA117673C2 (uk) 2018-09-10
MX2015008878A (es) 2015-10-30
JP6316846B2 (ja) 2018-04-25
SI2943503T1 (sl) 2017-11-30
IL239840A0 (en) 2015-08-31
CN104918951B (zh) 2018-03-30
CA2895910C (en) 2021-12-21
AU2014204873A1 (en) 2015-07-09
HUE034562T2 (en) 2018-03-28
EA027067B1 (ru) 2017-06-30
TWI613219B (zh) 2018-02-01
EP2943503A1 (en) 2015-11-18
CA2895910A1 (en) 2014-07-17
PT2943503T (pt) 2017-09-28
EA201591280A1 (ru) 2015-12-30
EP2943503B1 (en) 2017-08-23
JP2016505007A (ja) 2016-02-18
TW201429995A (zh) 2014-08-01

Similar Documents

Publication Publication Date Title
MX360905B (es) Polimixinas, composiciones, metodos de preparacion y metodos de uso.
MX359882B (es) Amidas como moduladores de canales de sodio.
MX2015009602A (es) Piridona amidas como moduladores de canales de sodio.
NZ716840A (en) Combination formulation of two antiviral compounds
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
MX362702B (es) Compuesto de semifluorocarbono que contiene agente de contraste.
CU24377B1 (es) Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
BR112014011938A2 (pt) combinação de formulação de dois compostos antivirais
BR112018003026A2 (pt) composições compreendendo um inibidor de pi3k e um inibidor de hdac
IN2015MN00405A (OSRAM)
CR20140091A (es) Nuevos derivados dihidroquinolina-2-ona
PH12016500643B1 (en) NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c'] DIPYRROL-2-YL
PH12017500513A1 (en) N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of nr2b
MX373622B (es) Mezclas de compuestos, su preparación y sus usos.
MX356342B (es) Agente de control de endoparásitos y método para usarlo.
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
DOP2014000178A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
SG10201803294PA (en) Tau imaging probe
IN2014CN01216A (OSRAM)
NZ703217A (en) Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same
MX2016014239A (es) Composicion limpiadora.
MA58019B1 (fr) Thienyloxazolones et analogues
SG10201805880UA (en) Emulsion composition for skin
PH12018500695A1 (en) Oral care compositions and methods of using the compositions

Legal Events

Date Code Title Description
FG Grant or registration